Pure Global

Topical Skin Application Solution - Vietnam Registration 240001670/PCBA-HN

Access comprehensive regulatory information for Topical Skin Application Solution in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 240001670/PCBA-HN and manufactured by ABI PHARMA Pharmaceutical Corporation. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN DƯỢC LIỆU CARERUM.

This page provides complete technical specifications, regulatory compliance details, 4 companies making similar products including ICCI Cosmetic Pharmaceutical Corporation, GOTIME ECO Science Co., Ltd, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
4 Competitors
5 Recent Registrations
240001670/PCBA-HN
Registration Details
Vietnam MOH Registration: 240001670/PCBA-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Topical Skin Application Solution
VN: DUNG DỊCH DÙNG NGOÀI DA
LÔXAIN
Risk Class TTBYT Loại A

Registration Details

240001670/PCBA-HN

000.00.19.H26-240813-0020

LÔXAIN

Company Information

CÔNG TY CỔ PHẦN DƯỢC LIỆU CARERUM

Technical Details

Supporting the treatment and healing (or re-epithelialization) of wounds (non-healing surgical wounds, chronic ulcers due to necrosis, surgical wounds, wounds from infections, skin and mucous membrane injuries in sensitive areas of the body such as the ear, nose, throat, mouth, gums, etc.) and burns, it helps reduce pain and burning sensation in burn wounds (boiling water burns, fire burns, lime burns, burns from motorcycles, burns from toxic insects like climbing fern, bed bugs, lice, red ants, etc., burns from nerve damage).

Dates and Status

Aug 14, 2024